Return to Listing

1 result(s) for

PI Name Protocol # Title
Jeremy Cetnar STUDY00016349 [Advarra – IAA] CINC280A2201: A phase II, multicenter, study of oral cMET inhibitor INC280 in adult patients with EGFR wild-type (wt), advanced non-small cell lung cancer (NSCLC)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080